Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19

BACKGROUND/AIMS: Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are limited. METHODS: Blood samples from adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Hye Hee, Lim, So Yun, Kwon, Ji-Soo, Kim, Ji Yeun, Bae, Seongman, Jung, Jiwon, Kim, Sung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925962/
https://www.ncbi.nlm.nih.gov/pubmed/35272444
http://dx.doi.org/10.3904/kjim.2021.409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925962/
https://www.ncbi.nlm.nih.gov/pubmed/35272444
http://dx.doi.org/10.3904/kjim.2021.409

Ejemplares similares